[A 5-year-old boy with nonconvulsive status epilepticus induced by theophylline treatment]

Tatsuro Nobutoki1, Jyun-ya Takahashi, Toshiaki Ihara

  • 1Department of Pediatrics, National Mie Hospital, Tsu, Mie. nbtk.yokohama.ped@biscuit.ocn.ne.jp

Insights

Theophylline therapy can trigger nonconvulsive status epilepticus (NCSE) in children, even after a convulsion is controlled. This condition, characterized by continuous seizure activity without convulsions, requires prompt recognition and treatment.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology

Background:

  • Theophylline is a common medication for pediatric respiratory conditions.
  • Generalized tonic-clonic convulsions are a known, albeit rare, adverse effect of theophylline.

Observation:

  • A 5-year-old boy experienced a generalized tonic-clonic convulsion during theophylline therapy.
  • Despite diazepam administration, the child remained unconscious, with EEG revealing nonconvulsive status epilepticus (NCSE).

Findings:

  • The patient's serum theophylline level was elevated at 19.7 microg/mL.
  • Midazolam treatment successfully suppressed the NCSE, first restricting it and then abolishing it completely.

Implications:

  • Theophylline-induced NCSE can occur even after initial convulsive seizure control.
  • Clinicians should consider NCSE in children on theophylline presenting with persistent altered consciousness.
  • This highlights the importance of monitoring for nonconvulsive seizures in susceptible pediatric patients.

Related Concept Videos

Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...